Your browser doesn't support javascript.
loading
Antileukemic activity of sulforaphane in primary blasts from patients affected by myelo- and lympho-proliferative disorders and in hypoxic conditions.
Fimognari, Carmela; Turrini, Eleonora; Sestili, Piero; Calcabrini, Cinzia; Carulli, Giovanni; Fontanelli, Giulia; Rousseau, Martina; Cantelli-Forti, Giorgio; Hrelia, Patrizia.
Afiliação
  • Fimognari C; Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Rimini, Italy.
  • Turrini E; Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Rimini, Italy.
  • Sestili P; Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
  • Calcabrini C; Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
  • Carulli G; Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Fontanelli G; Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Rousseau M; Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Cantelli-Forti G; Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Rimini, Italy.
  • Hrelia P; Department of Pharmacy and BioTechnology, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
PLoS One ; 9(7): e101991, 2014.
Article em En | MEDLINE | ID: mdl-25019218

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticarcinógenos / Isotiocianatos / Transtornos Linfoproliferativos / Transtornos Mieloproliferativos Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticarcinógenos / Isotiocianatos / Transtornos Linfoproliferativos / Transtornos Mieloproliferativos Idioma: En Ano de publicação: 2014 Tipo de documento: Article